Thymic involution: Where endocrinology meets immunology

NeuroImmunoModulation

Volumn 18, Issue 5, 2011, Pages 281-289

  Calder, Adrienne E ^a   Hince, Melanie N ^a   Dudakov, Jarrod A ^a   Chidgey, Ann P ^a   Boyd, Richard L ^a  

^a MONASH UNIVERSITY   (Australia)

Author keywords

Castration; Luteinizing hormone releasing hormone; Sex steroids; Thymic involution; Thymus

Indexed keywords

ANDROGEN RECEPTOR ANTAGONIST; ESTROGEN; ESTROGEN RECEPTOR; FLUTAMIDE; FOLLITROPIN; GONADORELIN; GONADORELIN AGONIST; GONADORELIN ANTAGONIST; GROWTH HORMONE; INTERLEUKIN 7; KERATINOCYTE GROWTH FACTOR; LUTEINIZING HORMONE; PROGESTERONE; SEX HORMONE; SOMATOMEDIN C; TESTOSTERONE; THYMUS HORMONE;

ABLATION THERAPY; ADAPTIVE IMMUNITY; AGING; ARTICLE; B LYMPHOCYTE; BONE MARROW; BREAST CANCER; CASTRATION; CD4+ T LYMPHOCYTE; CELL FUNCTION; CELL POPULATION; CELLULAR IMMUNITY; DISEASE EXACERBATION; ENDOCRINOLOGY; ENDOMETRIOSIS; HELPER CELL; HEMATOPOIESIS; HUMAN; HUMORAL IMMUNITY; IMMUNOLOGY; INVOLUTION; LYMPHOCYTE MIGRATION; MEMORY CELL; MYOMA; NONHUMAN; OVARIECTOMY; PRE T LYMPHOCYTE; PRECOCIOUS PUBERTY; PREGNANCY; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE HYPERTROPHY; PUBERTY; REJUVENATION; STROMA CELL; T LYMPHOCYTE; THYMOCYTE; THYMUS; THYMUS ATROPHY;

ALLERGY AND IMMUNOLOGY; ANIMALS; ENDOCRINE SYSTEM; ENDOCRINOLOGY; HUMANS; IMMUNE SYSTEM;

EID: 80053344687     PISSN: 10217401     EISSN: 14230216     Source Type: Journal    
DOI: 10.1159/000329496     Document Type: Article

References (99)

1. Hannoun C, Megas F, et al: Immunogenicity and protective efficacy of influenza vaccination. Virus Res 2004; 103: 133-138. (Pubitemid 38649072)
2. Kirschmann DA, Murasko DM: Effect of exogenous cytokines on the inhibition of macrophage-induced, antigen-specific T-cell proliferation by Poly(I-C). Clin Immunol Immunopathol 1992; 65: 300-307. (Pubitemid 23008452)
3. Kirschmann DA, Murasko DM: Splenic and inguinal lymph-node T-cells of aged mice respond differently to polyclonal and antigenspecific stimuli. Cell Immunol 1992; 139: 426-437.
4. Chakravarti B, Abraham GN: Aging and Tcell-mediated immunity. Mech Ageing Dev 1999; 108: 183-206.
5. Brelinska R: Thymic epithelial cells in agedependent involution. Microsc Res Tech 2003; 62: 488-500. (Pubitemid 37467326)
6. Sutherland JS, Goldberg GL, et al: Activation of thymic regeneration in mice and humans following androgen blockade. J Immunol 2005; 175: 2741-2753. (Pubitemid 41113891)
7. Aspinall R, Andrew D, et al: Age-Associated Changes in Thymopoiesis. Springer Semin Immunopathol 2002; 24: 87-101. (Pubitemid 34209114)
8. Chidgey A, Dudakov J, et al: Impact of niche aging on thymic regeneration and immune reconstitution. Semin Immunol 2007; 19: 331-340. (Pubitemid 350181532)
9. Fry TJ, Mackall CL: Current concepts of thymic aging. Springer Semin Immunopathol 2002; 24: 7-22. (Pubitemid 34209108)
10. Labrie F, Dupont A, et al: Combination therapy with flutamide and castration (LHRH agonist or orchiectomy) in advanced prostate cancer: A marked improvement in response and survival. J Steroid Biochem 1985; 23: 833-841. (Pubitemid 16183963)
11. Kendall MD, Fitzpatrick FT, et al: Reversal of ageing changes in the thymus of rats by chemical or surgical castration. Cell Tissue Res 1990; 261: 555-564. (Pubitemid 20271612)
12. Goldberg GL, Sutherland JS, et al: Sex steroid ablation enhances lymphoid recovery following autologous hematopoietic stem cell transplantation. Transplantation 2005; 80: 1604-1613. (Pubitemid 43005872)
13. Heng TSP, Goldberg GL, et al: Effects of castration on thymocyte development in two different models of thymic involution. J Immunol 2005; 175: 2982-2993. (Pubitemid 41170516)
14. Goldberg GL, Alpdogan O, et al: Enhanced immune reconstitution by sex steroid ablation following allogeneic hemopoietic stem cell transplantation. J Immunol 2007; 178: 7473-7484.
15. Sutherland JS, Spyroglou L, et al: Enhanced immune system regeneration in humans following allogeneic or autologous hemopoietic stem cell transplantation by temporary sex steroid blockade. Clin Cancer Res 2008; 14: 1138-1149. (Pubitemid 351302562)
16. Dudakov JA, Goldberg GL, et al: Withdrawal of sex steroids reverses age-and chemotherapy-related defects in bone marrow lymphopoiesis. J Immunol 2009; 182: 6247-6260.
17. Dudakov JA, Goldberg GL, et al: Sex steroid ablation enhances hematopoietic recovery following cytotoxic antineoplastic therapy in aged mice. J Immunol 2009; 183: 7084-7094.
18. Goldberg GL, King CG, et al: Luteinizing hormone-releasing hormone enhances T cell recovery following allogeneic bone marrow transplantation. J Immunol 2009; 182: 5846-5854.
19. Aspinall R, Andrew D: Thymic involution in aging. J Clin Immunol 2000; 20: 250-256. (Pubitemid 30619396)
20. Gruver A, Hudson L, et al: Immunosenescence of ageing. J Pathol 2007; 211: 144-156. (Pubitemid 46195513)
21. Dudakov JA, Khong DMP, et al: Feeding the fire: The role of defective bone marrow function in exacerbating thymic involution. Trends Immunol 2010; 31: 191-198.
22. Linton PJ, Dorshkind K: Age related changes in lymphocyte development and function. Nat Immunol 2004; 5: 133-139. (Pubitemid 38208354)
23. Aspinall R: Age-associated thymic atrophy in the mouse is due to a deficiency affecting rearrangement of the TCR during intrathymic T cell development. J Immunol 1997; 158: 3037-3045. (Pubitemid 127484015)
24. Nikolich-Zugich J: Ageing and life-long maintenance of T-cell subsets in the face of latent persistent infections. Nat Rev Immunol 2008; 8: 512-522. (Pubitemid 351913675)
25. Douek DC, McFarland RD, et al: Changes in thymic function with age and during the treatment of HIV infection. Nature 1998; 396: 690-695. (Pubitemid 29003949)
26. Haynes L, Eaton SM, et al: CD4 T cell memory derived from young naive cells functions well into old age, but memory generated from aged naive cells functions poorly. Proc Natl Acad Sci USA 2003; 100: 15053-15058. (Pubitemid 37518015)
27. Sansoni P, Vescovini R, et al: The immune system in extreme longevity. Exp Gerontol 2008; 43: 61-65.
28. Guevara-Patiño JA, Engelhorn ME, et al: Optimization of a self antigen for presentation of multiple epitopes in cancer immunity. J Clin Invest 2006; 116: 1382-1390.
29. Maue AC, Yager EJ, et al: T-cell immunosenescence: Lessons learned from mouse models of aging. Trends Immunol 2009; 30: 301-305.
30. Liu WM, van der Zeijst BAM, et al: Aging and impaired immunity to influenza viruses. Implications for vaccine development. Hum Vaccin 2011; 7: 94-98.
31. van den Brink MRM, Alpdogan O, et al: Strategies to enhance T-cell reconstitution in immunocompromised patients. Nat Rev Immunol 2004; 4: 856-867. (Pubitemid 39490761)
32. Olsen NJ, Watson MB, et al: Androgen deprivation induces phenotypic and functional changes in the thymus of adult male mice. Endocrinology 1991; 129: 2471-2476.
33. Goldberg GL, Dudakov JA, et al: Sex steroid ablation enhances immune reconstitution following cytotoxic antineoplastic therapy in young mice. J Immunol 2010; 184: 6014-6024.
34. Metallinou C, Asimakopoulos B, et al: Gonadotropin-releasing hormone in the ovary. Reprod Sci 2007; 4: 737-749. (Pubitemid 351903555)
35. Barnard A, Layton D, et al: Impact of the neuroendocrine system on thymus and bone marrow function. Neuroimmunomodulation 2008; 15: 7-18.
36. Conn PM, Crowley WF Jr: Gonadotropinreleasing hormone and its analogs. Annu Rev Med 1994; 45: 391-405.
37. Greenstein BD, Fitzpatrick FT, et al: Reappearance of the thymus in old rats after orchidectomy: Inhibition of regeneration by testosterone. J Endocrinol 1986; 110: 417-422. (Pubitemid 16052771)
38. Greenstein BD, Fitzpatrick FT, et al: Regeneration of the thymus in old male rats treated with a stable analogue of LHRH. J Endocrinol 1987; 112: 345-350. (Pubitemid 17020868)
39. Olsen NJ, Kovacs WJ: Increased thymic size and thymocyte interleukin-2 production in androgen-resistant mice. Scand J Immunol 1989; 29: 733-738. (Pubitemid 19160948)
40. Marchetti B, Guarcello V, et al: Luteinizing hormone-releasing hormone-binding sites in the rat thymus: Characteristics and biological function. Endocrinology 1989; 125: 1025-1036. (Pubitemid 19205102)
41. Marchetti B, Guarcello V, et al: Luteinizing hormone-releasing hormone (LHRH) agonist restoration of age-associated decline of thymus weight, thymic LHRH receptors, and thymocyte proliferative capacity. Endocrinology 1989; 125: 1037-1045. (Pubitemid 19205103)
42. Standaert FE, Chew BP, et al: Presence of luteinizing hormone-releasing hormone binding sites in cultured porcine lymphocytes. Biol Reprod 1992; 46: 997-1000.
43. Chen HF, Jeung EB, et al: Human peripheral blood mononuclear cells express gonadotropin-releasing hormone (GnRH), GnRH receptor, and interleukin-2 receptor gammachain messenger ribonucleic acids that are regulated by GnRH in vitro. J Clin Endocrinol Metab 1999; 84: 743-750.
44. Dixit VD, Yang H, et al: Gonadotropin-releasing hormone alters the T helper cytokine balance in the pregnant rat. Biol Reprod 2003; 68: 2215-2221. (Pubitemid 36687014)
45. Berruti A, Dogliotti L, et al: Changes in bone mineral density, lean body mass and fat content as measured by dual energy X-ray absorptiometry in patients with prostate cancer without apparent bone metastases given androgen deprivation therapy. J Urol 2002; 167: 2361-2367. (Pubitemid 34533125)
46. Kung AW: Androgen and bone mass in men. Asian J Androl 2003; 5: 148-154. (Pubitemid 36758333)
47. Kincade PW, Medina KL, et al: Early B-lymphocyte precursors and their regulation by sex steroids. Immunol Rev 2000; 175: 128-137. (Pubitemid 30427163)
48. Leposavic G, Perisic M, et al: Neonatal testosterone imprinting affects thymus development and leads to phenotypic rejuvenation and masculinization of the peripheral blood T-cell compartment in adult female rats. Brain Behav Immun 2009; 23: 294-304.
49. Guevara Patiño JA, Marino MW, et al: Sex steroids induce apoptosis of CD8+CD4+ double-positive thymocytes via TNF-alpha. Eur J Immunol 2000; 30: 2586-2592.
50. Shames RS: Gender differences in the development and function of the immune system. J Adolesc Health 2002; 30(4 suppl):59-70. (Pubitemid 34275454)
51. Staples JE, Gasiewicz TA, et al: Estrogen receptor alpha is necessary in thymic development and estradiol-induced thymic alterations. J Immunol 1999; 163: 4168-4174. (Pubitemid 29474479)
52. Yellayi S, Teuscher C, et al: Normal development of thymus in male and female mice requires estrogen/estrogen receptor-alpha signaling pathway. Endocrine 2000; 12: 207-213. (Pubitemid 30432235)
53. Erlandsson MC, Ohlsson C, et al: Role of oestrogen receptors alpha and beta in immune organ development and in oestrogen-mediated effects on thymus. Immunology 2001; 103: 17-25. (Pubitemid 32453095)
54. Shim GJ, Wang L, et al: Disruption of the estrogen receptor beta gene in mice causes myeloproliferative disease resembling chronic myeloid leukemia with lymphoid blast crisis. Proc Natl Acad Sci USA 2003; 100: 6694-6699. (Pubitemid 36675339)
55. Viselli SM, Olsen NJ, et al: Immunochemical and flow cytometric analysis of androgen receptor expression in thymocytes. Mol Cell Endocrinol 1995; 109: 19-26.
56. Olsen NJ, Gu X, et al: Bone marrow stromal cells mediate androgenic suppression of B lymphocyte development. J Clin Invest 2001; 108: 1697-1704. (Pubitemid 33144879)
57. Olsen N, Olson G, et al: Androgen receptors in thymic epithelium modulate thymus size and thymocyte development. Endocrinology 2001; 142: 1278-1283. (Pubitemid 32202839)
58. Rijhsinghani AG, Bhatia SK, et al: Effect of pregnancy on thymic T cell development. Am J Reprod Immunol 1996; 35: 523-528. (Pubitemid 26172351)
59. Zoller AL, Schnell FJ, et al: Murine pregnancy leads to reduced proliferation of maternal thymocytes and decreased thymic emigration. Immunology 2007; 121: 207-215. (Pubitemid 46663089)
60. Sacks G, Sargent I, et al: An innate view of human pregnancy. Immunol Today 1999; 20: 114-118.
61. Purton JF, Monk JA, et al: Expression of the glucocorticoid receptor from the 1A promoter correlates with T lymphocyte sensitivity to glucocorticoid-induced cell death. J Immunol 2004; 173: 3816-3824. (Pubitemid 39280744)
62. Tibbetts TA, DeMayo F, et al: Progesterone receptors in the thymus are required for thymic involution during pregnancy and for normal fertility. Proc Natl Acad Sci USA 1999; 96: 12021-12026. (Pubitemid 29502851)
63. Phuc LH, Papiernik M, et al: Thymic involution in pregnant mice. 1. Characterization of the remaining thymocyte subpopulations. Clin Exp Immunol 1981; 44: 247-252. (Pubitemid 11150255)
64. Henderson J: On the relationship of the thymus to the sexual organs. 1. The influence of castration on the thymus. J Physiol (Lond) 1904; 31: 222-229.
65. Min H, Montecino-Rodriguez, et al: Reassessing the role of growth hormone and sex steroids in thymic involution. Clin Immunol 2006; 118: 117-123. (Pubitemid 43012054)
66. Gray DH, Seach N, et al: Developmental kinetics, turnover, and stimulatory capacity of thymic epithelial cells. Blood 2006; 108: 3777-3785. (Pubitemid 44864559)
67. Aw D, Silva AB, et al: Immunosenescence: Emerging challenges for an ageing population. Immunology 2007; 120: 435-446. (Pubitemid 46365019)
68. Leposavic G, Obradovic S, et al: In vivo modulation of the distribution of thymocyte subsets by female sex steroid hormones. Int Immunopharmacol 2001; 1: 1-12. (Pubitemid 32193597)
69. Garcia-Perez MA, Del Val R, et al: Estrogen receptor agonists and immune system in ovariectomized mice. Int J Immunopathol Pharmacol 2006; 19: 807-819. (Pubitemid 46145044)
70. Utsuyama M, Hirokawa K: Hypertrophy of the thymus and restoration of immune functions in mice and rats by gonadectomy. Mech Ageing Dev 1989; 47: 175-185. (Pubitemid 19084871)
71. Zhao H, Tian Z, et al: Extragonadal aromatization increases with time after ovariectomy in rats. Reprod Biol Endocrinol 2005; 3: 6.
72. Mattsson C, Olsson T: Estrogens and glucocorticoid hormones in adipose tissue metabolism. Curr Med Chem 2007; 14: 2918-2924. (Pubitemid 350201658)
73. Forsberg JG: Neonatal estrogen treatment and its consequences for thymus development, serum level of autoantibodies to cardiolipin, and the delayed-type hypersensitivity response. J Toxicol Environ Health A 2000; 60: 185-213.
74. Cutolo M, Sulli A, et al: Sex hormones influence on the immune system: Basic and clinical aspects in autoimmunity. Lupus 2004; 13: 635-638. (Pubitemid 39279773)
75. Linde R, Doelle GC, et al: Reversible inhibition of testicular steroidogenesis and spermatogenesis by a potent gonadotropin-releasing hormone agonist in normal men: An approach toward the development of a male contraceptive. N Engl J Med 1981; 305: 663-667. (Pubitemid 11056134)
76. Pinski J, Yano T, et al: Blockade of the LH response induced by the agonist D-Trp-6-LHRH in rats by a highly potent LH-RH antagonist SB-75. Prostate 1992; 20: 213-224.
77. Engel JB, Schally AV: Drug insight: Clinical use of agonists and antagonists of luteinizing-hormone-releasing hormone. Nat Clin Pract Endocrinol Metab 2007; 3: 157-167. (Pubitemid 46146968)
78. Reissmann T, Schally AV, et al: The LHRH antagonist Cetrorelix: A review. Hum Reprod Update 2000; 6: 322-331. (Pubitemid 30657786)
79. Tombal B: Appropriate castration with lu teinising hormone releasing hormone (LHRH) agonists: What is the optimal level of testosterone? Eur Urol Suppl 2005; 4: 14-19. (Pubitemid 40780974)
80. Hince M, Sakkal S, et al: The role of sex steroids and gonadectomy in the control of thymic involution. Cell Immunol 2008; 252: 122-138.
81. Kelly RM, Highfill SL, et al: Keratinocyte growth factor and androgen blockade work in concert to protect against conditioning regimen-induced thymic epithelial damage and enhance T-cell reconstitution after murine bone marrow transplantation. Blood 2008; 111: 5734-5744.
82. Lynch HE, Goldberg GL, et al: Thymic involution and immune reconstitution. Trends Immunol 2009; 30: 366-373.
83. Azad N, LaPaglia N, et al: The role of gonadectomy and testosterone replacement on thymic luteinizing hormone-releasing hormone production. J Endocrinol 1998; 158: 229-235. (Pubitemid 28342067)
84. Marchetti B, Gallo F, et al: Gender, neuroendocrine-immune interactions and neuronglial plasticity. Role of luteinizing hormonereleasing hormone (LHRH). Ann NY Acad Sci 2000; 917: 678-709.
85. Batticane N, Morale MC, et al: Luteinizing hormone-releasing hormone signaling at the lymphocyte involves stimulation of interleukin-2 receptor expression. Endocrinology 1991; 129: 277-286.
86. Kyama CM, Debrock S, et al: Potential involvement of the immune system in the development of endometriosis. Reprod Biol Endocrinol 2003; 1: 123.
87. Wong KH, Simon JA: In vitro effect of gonadotropin-releasing hormone agonist on natural killer cell cytolysis in women with and without endometriosis. Am J Obstet Gynecol 2004; 190: 44-49. (Pubitemid 38156321)
88. Denmeade SR, Isaacs JT: A history of prostate cancer treatment. Nat Rev Cancer 2002; 2: 389-396. (Pubitemid 37328952)
89. O'Bryant CL, Flaig TW, et al: Bicalutamideassociated fulminant hepatotoxicity. Pharmacotherapy 2008; 28: 1071-1075.
90. Bartke A, Mason M, et al: Effects of tamoxifen on plasma concentrations of testosterone and gonadotrophins in the male rat. J Endocrinol 1978; 79: 239-240. (Pubitemid 9052008)
91. Sfikakis PP, Kostomitsopoulos N, et al: Tamoxifen exerts testosterone-dependent and independent effects on thymic involution. Int J Immunopharmacol 1998; 20: 305-312. (Pubitemid 28383456)
92. Murphy WJ, Durum SK, et al: Immunologic and hematologic effects of neuroendocrine hormones. Studies on DW/J dwarf mice. J Immunol 1992; 148: 3799-3805.
93. Taub DD, Tsarfaty G, et al: Growth hormone promotes human T cell adhesion and migration to both human and murine matrix proteins in vitro and directly promotes xenogeneic engraftment. J Clin Invest 1994; 94: 293-300. (Pubitemid 24218104)
94. Min D, Taylor PA, et al: Protection from thymic epithelial cell injury by keratinocyte growth factor: A new approach to improve thymic and peripheral T-cell reconstitution after bone marrow transplantation. Blood 2002; 99: 4592-4600. (Pubitemid 34627232)
95. Alpdogan O, Muriglan SJ, et al: IL-7 enhances peripheral T cell reconstitution after allogeneic hematopoietic stem cell transplantation. J Clin Invest 2003; 112: 1095-1107. (Pubitemid 38056324)
96. Carlo-Stella C, Di Nicola M, et al: Use of recombinant human growth hormone (rhGH) plus recombinant human granulocyte colony-stimulating factor (rhG-CSF) for the mobilization and collection of CD34+ cells in poor mobilizers. Blood 2004; 103: 3287-3295. (Pubitemid 38525653)
97. Alpdogan O, Hubbard VM, et al: Keratinocyte growth factor (KGF) is required for postnatal thymic regeneration. Blood 2006; 107: 2453-2460. (Pubitemid 43345567)
98. Aspinall R, Pido-Lopez J, et al: Old rhesus macaques treated with interleukin-7 show increased TREC levels and respond well to influenza vaccination. Rejuvenation Res 2007; 10: 5-17. (Pubitemid 46449428)
99. Seggewiss R, Lore K, et al: Keratinocyte growth factor augments immune reconstitution after autologous hematopoietic progenitor cell transplantation in rhesus macaques. Blood 2007; 10: 441-449. (Pubitemid 47026867)